본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

BMA Biomedicals

[BMA Biomedicals] Liraglutide ELISA

Cat-No. S-1502



BMA Biomedicals는 생명과학 연구를 위한 고품질 항체와 관련 제품을 제공하는 전문 생명공학 회사입니다.




제품 설명


Liraglutide ELISA




제품 번호


S-1502




제품 특징


Liraglutide (Victoza®), ELISA Kit, high sensitivity. 

Note: Ships without standard substance (patent-protected).

Clone polyclonal 
Format Kit 
Applications High Sensitivity 
Host Species Rabbit

Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) agonist, derived from human GLP1-(7-37), a less common form of endogenous GLP-1. It reduces meal-related hyperglycemia, delaying gastric emptying, and suppressing prandial glucagon secretion. Liraglutide is sold as a medication used to treat diabetes mellitus type 2 and obesity. The prolonged action of liraglutide (as compared to endogenous GLP-1) is achieved by attaching a fatty acid molecule at one position of the GLP-1-(7-37) molecule, enabling it to both self-associate and bind to albumin within the subcutaneous tissue and bloodstream. The active GLP-1 is then released from albumin at a slow, consistent rate. This ELISA was developed with serum from rabbits immunized with Liraglutide coupled to a carrier protein.







BMA Biomedicals의 모든 제품을 만나 보세요!


Antibodies

ELISA kits & Reagents


BMA Biomedicals - Official Distributor in South Korea "Morebio" 한국 공식 대리점 "모아바이오"